Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study

Fig. 1

Flow chart of analysis criteria. PFS was analysed in 20 patients, after 2 had been withdrawn, due to rapid development of CNS metastasis and continuous neutropenia. Of these 20 patients, we were able to evaluate clinical responses based on imaging in 18. Thirteen patients, with at least 4 total CTCs or any mCTCs at baseline, underwent a second CTC test when treatment effects were assessed

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us